Appointment reinforces leadership in advancing patient safety, quality care, and accreditation across India’s healthcare ecosystemChennai, April 2026: The Consortium of Accredited Healthcare Organizations (CAHO) has appointed Dr Ilankumaran Kaliamoorthy, Chief Executive Officer, Apollo Hospitals - Chennai Region, as Chairperson of its Healthcare Institutions Division for the 2026–2028 term. CAHO, a leading body focused on advancing patient safety and quality standards across healthcare institutions in India, brings together accredited hospitals and healthcare providers to drive best practices, clinical governance, and system-wide improvements.In his role as Chairperson of the Healthcare Institutions Division, Dr Kaliamoorthy will work closely with member institutions to strengthen quality frameworks, promote standardisation of care, and enable knowledge-sharing across the ecosystem. The focus will be on building scalable, sustainable approaches to accreditation, patient safety, and clinical excellence across diverse care settings.Dr Kaliamoorthy brings extensive experience in hospital administration and clinical operations, with a strong track record in driving quality-led healthcare delivery. At Apollo Hospitals, Chennai Region, he has led initiatives focused on clinical outcomes, operational efficiency, and patient-centric care models.Commenting on the appointment, Dr Ilankumaran Kaliamoorthy said, “This is an important moment for healthcare in India, where the focus is increasingly shifting towards measurable quality, patient safety, and accountability across institutions. CAHO has played a critical role in shaping this agenda, and I look forward to working with member organisations to strengthen systems that deliver consistent, high-quality care. The priority will be to translate standards into everyday practice and support institutions in building capabilities that are both scalable and sustainable.”The appointment comes at a time when healthcare systems across India are placing greater emphasis on accreditation, transparency, and continuous quality improvement, with industry bodies like CAHO playing a key role in enabling alignment and progress across institutions.For more informations, Click here https://www.apollohospitals.com/apollo-in-the-news

 Advanced minimally invasive approach expands treatment options for patients unsuitable for repeat open-heart surgery Chennai, India: Apollo Hospitals, Greams Road, Chennai has successfully treated a high-risk 67-year-old patient with complex heart disease using a rare BASILICA-assisted Transcatheter Aortic Valve Implantation (TAVI) procedure, helping prevent a potentially life-threatening complication during valve replacement.  The advanced minimally invasive procedure was carried out by a multidisciplinary cardiac team led by Dr. Sengottuvelu G, Senior Interventional Cardiologist and the Clinical Lead of Structural Heart Interventions, Apollo Hospitals. This approach is particularly relevant for patients who are not ideal candidates for repeat open-heart surgery, offering a less invasive alternative in complex redo valve cases. The patient presented a complicated medical history, including diabetes, coronary artery disease with prior stent placement, and a previous surgical aortic valve replacement in 2017 for bicuspid aortic stenosis. Over time, the artificial valve deteriorated, leading to severe aortic stenosis and moderate aortic regurgitation, resulting in recurring symptoms and the need for further intervention. Pre-procedure imaging revealed a critical challenge. The coronary arteries, which supply blood to the heart, were located very close to the existing valve. In such cases, placing a new valve can push the valve leaflet into these arteries, potentially blocking blood flow and leading to life-threatening complications. To address this, the team performed a minimally invasive TAVI procedure, where a new valve is delivered through a blood vessel, typically via the leg. Given the high risk of coronary obstruction, this was combined with the BASILICA technique, an advanced method designed to prevent blockage. Dr. Sengottuvelu G, Senior Interventional Cardiologist and Clinical Lead of Structural Heart Interventions, Apollo Hospitals Chennai, said, "This case highlights the evolving capabilities of transcatheter therapies in managing highly complex structural heart disease. BASILICA is a technically demanding procedure, and its successful execution reflects the expertise and coordination of our team." During the procedure, a fine wire was carefully positioned across the valve leaflet that posed the risk. Using a controlled burst of electrical energy, the team precisely split the leaflet. Once divided, the two halves move aside when the new valve is placed, ensuring that blood flow to the coronary arteries is not obstructed. As an added layer of safety, guidewires were placed in both coronary arteries, with backup stents kept ready for immediate use, ensuring that blood flow could be restored instantly if required. Dr. C S Muthukumaran, Interventional Cardiologist, Apollo Hospitals Chennai, added, “Performing the first BASILICA procedure in the Apollo Group is a proud moment. It reinforces our commitment to bringing cutting-edge, life-saving technologies to patients in India.” Following the procedure, the team successfully implanted a transcatheter heart valve, achieving an excellent clinical outcome. The patient showed improved blood flow through the valve, no obstruction to the coronary arteries, stable heart rhythm, and has since been discharged in a stable condition. While coronary artery obstruction during TAVI is rare (occurring in less than 1% of cases), it carries a high mortality risk of up to 40–50%, making prevention critical. Techniques such as BASILICA have been developed globally for such high-risk cases, with success rates exceeding 90% in international studies. However, the procedure remains highly specialised and is not widely performed, particularly in India. This case reflects the growing role of advanced structural heart interventions in managing complex cardiac conditions, while reducing the need for repeat open surgeries and enabling faster recovery for patients.Featuring insights from Dr. Sengottuvelu G, Senior Interventional Cardiologist and Clinical Lead of Structural Heart Interventions, Apollo Hospitals Chennai. And Dr. C S Muthukumaran, Interventional Cardiologist, Apollo Hospitals Chennai 📞 For appointments, call 044 4040 1066

India’s health risks are emerging earlier and often remaining undetected for longer, according to the sixth edition of Apollo Hospitals’ Health of the Nation (HoN) 2026 report, released on World Health Day. Based on over three million preventive health assessments conducted across the Apollo ecosystem in 2025, the report highlights a growing need for proactive and personalised healthcare approaches.  The analysis shows that two in three young adults are already at risk for non-communicable diseases (NCDs). In working populations with an average age of 38, nearly half have prediabetes or diabetes, while eight in ten are overweight. Notably, one in five individuals under 30 is prediabetic, though early intervention has been shown to reverse the condition in many cases. The report also reveals widespread nutritional and fitness concerns, including high rates of Vitamin D and B12 deficiencies and declining physical fitness among younger individuals. Notably, nearly two-thirds of people under 30 assessed showed limitations in strength, flexibility, or balance, early indicators associated with higher long-term risks for cardiovascular disease and reduced physical resilience. Gender-specific insights further highlight risks such as anaemia and the earlier onset of breast cancer, reinforcing the importance of targeted screening and timely preventive care.   Dr. Prathap C. Reddy, Founder Chairman, Apollo Hospitals, emphasised that healthcare must move beyond routine tests to a more personalised and proactive model, where comprehensive health checks help individuals understand long-term risks and take greater ownership of their well-being. Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals, noted that women’s health requires more personalised and life-stage–aligned care, as undetected health conditions can have far-reaching impacts on families, communities, and the broader economy. Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals, highlighted that healthy longevity depends on early and continuous action, with predictive screening and advanced diagnostics playing a key role in identifying diseases such as heart disease and cancer at their earliest, most treatable stages. The report reinforces that structured screening, advanced diagnostics, and follow-up care can significantly improve health outcomes, marking a shift toward predictive, preventive, and personalised healthcare in India. 

Apollo Hospitals, Chennai, continues to strengthen its leadership in advanced surgical innovation, as Dr. Venkatesh Munikrishnan, Consultant Colorectal Surgeon, was conferred the Lifetime Achievement Award for services to robotic colorectal surgery at the 3rd Global SSI Multi-Specialty Robotic Surgery Conference (SMRSC 2026) in New Delhi.  Presented by the Hon’ble Minister of State for Health & Family Welfare Mr. Prataprao Jadhav, the award reflects both individual excellence and the collective clinical advancements achieved by the Apollo Hospitals team. Over the years, the colorectal unit at Apollo has contributed to one of India’s largest series of robotic colorectal cancer surgeries, demonstrating the growing role of minimally invasive, robot-assisted techniques in improving surgical precision and patient recovery. Robotic colorectal surgery is increasingly recognised for its potential to enhance surgical dexterity, enable better visualisation, and support more precise tumour resection, particularly in complex pelvic procedures. At Apollo, these capabilities have been complemented by the development of a telesurgery service chain, expanding access to specialised care and enabling knowledge-sharing across geographies. The recognition also highlights the institution’s commitment to integrating innovation with patient-first care, ensuring that technological advancements translate into safer procedures and improved outcomes. As robotic platforms continue to evolve, Apollo Hospitals remains focused on advancing evidence-based surgical practices that prioritise precision, accessibility, and long-term patient well-being. 

Family enterprises remain central to India’s economic fabric, with nearly 8 out of 10 businesses being family-owned or family-controlled. Recognising this significant contribution, the ET Family Business Awards brought together industry leaders to celebrate the legacy, resilience, and innovation that define these institutions.  The all-star jury was chaired by Dr. Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals Enterprise, alongside distinguished business leaders representing diverse sectors. The deliberations reflected a rigorous evaluation process, underscoring the depth of achievement and strategic excellence demonstrated by India’s leading family businesses. From detailed nomination reviews to nuanced discussions, the jury process highlighted the complexity of evaluating organisations that successfully balance legacy with modern growth strategies. Attention was drawn to next-generation leaders, whose ability to carry forward institutional values while embracing innovation stood out across categories. Summarising the process, Dr. Preetha Reddy noted, “The ET Family Business Awards stood out for its rigour—thorough nominations and a jury that spoke with one voice. With family businesses driving 79% of our economy, this recognition is a tribute to the quiet, generational strength that powers India.” Family-led healthcare institutions, including Apollo Hospitals, continue to play a pivotal role in building resilient, patient-centric care ecosystems. By combining clinical expertise with long-term vision, these organisations are advancing healthcare access, quality, and innovation across the country. As India’s healthcare landscape evolves, the sustained leadership of family enterprises will remain critical in delivering trusted, future-ready care at scale. 

Senior interventional cardiologist Dr. Sengottuvelu G from Apollo Hospitals, Chennai, has been conferred the prestigious Fellowship of the Japanese Circulation Society (FJCS), marking a significant milestone in global cardiovascular medicine. The recognition highlights his contributions to advancing interventional cardiology and reinforces India’s presence on the international clinical stage.  With over 25 years of experience, Dr. Sengottuvelu is widely regarded for his expertise in complex coronary interventions, structural heart disease management, and transcatheter therapies such as TAVI (Transcatheter Aortic Valve Implantation). He has performed many cardiac procedures and has been at the forefront of adopting evidence-based, minimally invasive techniques that improve patient outcomes and recovery timelines.   The FJCS honour reflects not only individual excellence but also the increasing global collaboration in cardiovascular care. Recognition by an international body such as the Japanese Circulation Society underscores the importance of innovation, precision, and adherence to evolving clinical standards in treating complex cardiac conditions. For patients, such achievements translate into greater access to advanced therapies delivered by globally acknowledged experts. For clinicians and the broader healthcare ecosystem, it reinforces the value of continuous research, skill advancement, and cross-border knowledge exchange. As cardiovascular disease remains a leading health concern, milestones like this strengthen trust in India’s ability to deliver world-class, outcomes-driven cardiac care.

Apollo Hospitals, Chennai, has marked a major milestone in neurological care with the successful clinical activation of India’s first Adaptive Deep Brain Stimulation (aDBS) for Parkinson’s disease. Performed on March 2, 2026, by Dr. Vijayashankar Paramanandam, Senior Consultant Neurologist and Movement Disorders & Deep Brain Stimulation (DBS) Specialist, Dr. Arvind Sukumaran, Senior Consultant Neurosurgeon, and a multidisciplinary team, the procedure reflects a significant advancement in precision-driven therapy for movement disorders.  Announced on World Parkinson’s Day, the achievement highlights the growing need for awareness, early diagnosis, and timely access to advanced treatment options. Parkinson’s disease continues to pose a rising public health challenge, with projections indicating a substantial increase in cases across India and globally in the coming decades. Building on the hospital’s established Deep Brain Stimulation (DBS) programme, Adaptive DBS introduces a more responsive approach to therapy. Unlike conventional DBS, which delivers continuous stimulation, aDBS interprets the brain’s electrical activity in real time and adjusts stimulation accordingly. This enables more precise symptom control and better alignment with daily fluctuations in motor function. Dr. Paramanandam noted that Adaptive DBS represents a significant evolution in Parkinson’s therapy, as it continuously responds to the brain’s signals to deliver tailored stimulation, helping reduce symptom unpredictability and improve quality of life. Dr. Sukumaran added that early clinical follow-up has shown encouraging improvements in day-long stability — an important outcome in managing Parkinson’s-related fluctuations. The first patient, a 62-year-old male, reported improved steadiness throughout the day, underscoring the real-world impact of this innovation. This milestone reinforces Apollo Hospitals’ commitment to advancing evidence-based, patient-centric care through cutting-edge neurological interventions. 

Milestone highlights the shift toward real-time, personalised neuromodulation in Parkinson’s treatmentAnnounced on the occasion of World Parkinson’s Day, underscoring the need for awareness and timely access to advanced therapiesCHENNAI, India – 11 April 2026: Apollo Hospitals, Chennai announces a major milestone in the treatment of Parkinson’s disease in India, the country’s first clinical activation of Adaptive Deep Brain Stimulation (aDBS). The procedure was carried out on 2 March 2026 by Dr. Vijayashankar Paramanandam, Dr. Arvind Sukumaran, and their team. The programme is led by clinicians with advanced international fellowship training in movement disorders neurology and functional neurosurgery.  A recent British Medical Journal study underscores the rising burden of Parkinson’s disease in India, with an estimated 2.8 million people expected to be living with the condition by 2050 (range 2.3–3.5 million), second only to China and accounting for nearly one-tenth of global cases. South Asia is projected to contribute nearly 6.8 million cases overall. Globally, the Parkinson’s population is expected to reach 25.2 million—up over 112% from 2021 levels—with India alone projected to see a 160–180% increase. Current global prevalence stands at 267 cases per one lakh people. The milestone builds on the hospital’s established Deep Brain Stimulation (DBS) programme, developed through sustained experience in movement disorders and functional neurosurgery. This follows an initial period of clinical follow-up to assess the patient’s response to the treatment. Conventional DBS has transformed care for appropriately selected Parkinson’s patients by delivering continuous electrical stimulation to targeted areas of the brain. Adaptive DBS fine tunes it by introducing a more responsive approach, adjusting stimulation in real time based on the patient’s own brain signals. This approach is supported by sensing-enabled neurostimulation systems, including those developed by Medtronic, allowing therapy to better align with fluctuations in symptoms across the day. Adaptive DBS is an important advance in Parkinson’s therapy,” said Dr. Vijayashankar Paramanandam, Senior Consultant Neurologist & Movement Disorders and DBS Specialist, Apollo Hospitals, Greams Lane-Chennai. “Adaptive DBS represents the next major evolution from conventional, continuous DBS therapy. By actively monitoring the brain’s unique electrical signals, the system responds instantaneously, delivering the precise amount of stimulation exactly when it is needed. This effectively smooths out unpredictable symptoms and improves the quality of life , bringing us closer to truly personalized DBS care.” “In any new technology, what matters is patient benefit,” said Dr. Arvind Sukumaran, Senior Consultant Neurosurgeon, Apollo Hospitals, Greams Lane- Chennai. “Following activation, programming and clinical follow-up over a month, we have seen encouraging early response in terms of stability throughout the day. That is a meaningful outcome in Parkinson’s, where fluctuation is often the most challenging aspect to manage.” The patient, a 62-year-old male, also reported meaningful improvement. “I feel more stable through the day, and that makes a real difference to daily life,” he said. Parkinson’s disease is a progressive neurological condition that affects movement, independence, and quality of life. Patients who have lived with the disease for several years, require multiple medications, and experience significant “off” periods or dyskinesias may benefit from timely referral for advanced therapies such as DBS.  Observed every year on April 11, World Parkinson’s Day highlights the need for greater awareness, early diagnosis, and improved access to care. This development reflects the growing role of advanced, physiology-guided therapies in addressing unmet needs in Parkinson’s management in India. For Appointments, Click Here

Apollo Hospitals Chennai has inaugurated a new Information Centre in Chattogram, Bangladesh, reinforcing its commitment to expanding access to high-quality healthcare services for international patients. The centre, located in the Jamal Khan area of the city, was inaugurated by Naveen Varigepalli, CEO of Apollo Hospitals Chennai, along with Dr. Ilankumaran Kaliamoorthy, Regional CEO – Chennai Region, Apollo Hospitals. Mr. MS Guru Prasad, Associate Vice President – International Sales & Marketing, Apollo Hospitals Group, was also present at the ceremony.   The facility is designed to serve as a dedicated patient support hub, helping individuals in Bangladesh connect with Apollo’s specialists and advanced medical services in India. Through the centre, patients can access assistance with doctor appointments, second opinions, treatment planning, and visa facilitation — ensuring a seamless pathway to specialised care.   Beyond patient services, the centre will also collaborate with local physicians and medical value travel professionals to coordinate care and provide reliable clinical guidance. This integrated approach aims to support patients from the early stages of medical consultation through treatment planning and follow-up.  Importantly, the initiative will promote professional knowledge-sharing through Continuing Medical Education (CME) seminars and patient awareness programmes, strengthening clinical collaboration and healthcare education in the region.  Dr. Ilankumaran thanked the people of Bangladesh for their continued trust in Apollo Hospitals and reaffirmed the organisation’s commitment to strengthening this relationship while delivering compassionate, high-quality care through collaboration and clinical excellence.  Apollo Hospitals has long been a preferred destination for international patients seeking advanced treatments across specialties such as cardiology, oncology, and neurosciences. By establishing this information centre, Apollo Hospitals continues to bridge geographical barriers; bringing trusted medical expertise closer to patients while reinforcing its commitment to accessible, patient-centred healthcare across borders. 

At the ET Now Business Conclave & Awards 2026, Dr. (Prof.) Ameet Kishore, Senior Consultant in ENT & Neurotology at Indraprastha Apollo Hospitals, New Delhi, was honoured with the Excellence Award for his outstanding contributions to ENT, Head & Neck surgery, and cochlear implant care. The recognition reflects his long-standing commitment to advancing hearing restoration and patient-centred clinical innovation.  With more than 25 years of experience in otorhinolaryngology, Dr. Kishore is widely regarded for his expertise in complex ear surgery, neuro-otology, pediatric ENT, and implantable hearing technologies. Trained in the United Kingdom with fellowships from the Royal College of Surgeons of Edinburgh and the Royal College of Physicians and Surgeons of Glasgow, he has played a pivotal role in bringing advanced global standards of ENT care to India.   At Apollo Hospitals, Dr. Kishore established and leads a comprehensive cochlear and hearing implant programme, providing life-changing treatment for children and adults with severe to profound hearing loss. Over the years, the programme has supported more than 1,800 cochlear implant recipients, helping patients regain hearing ability, communication skills, and improved quality of life.   Beyond clinical practice, he has contributed extensively to academic research, medical education, and national initiatives in auditory rehabilitation. His work continues to shape the future of hearing healthcare in India, particularly in advancing multidisciplinary approaches for complex auditory disorders. This recognition underscores Apollo Hospitals’ ongoing commitment to clinical excellence, innovation, and patient-focused care, while celebrating the contributions of physicians who continue to transform lives through advanced medical science. 

Apollo Hospitals Navi Mumbai has launched a dedicated Pediatric Rehabilitation Unit, further strengthening its child recovery services and advancing comprehensive care for young patients. The specialised unit is designed to support children recovering from illness, injury, surgery, or developmental conditions through coordinated, multidisciplinary rehabilitation.   Pediatric rehabilitation plays a crucial role in helping children regain physical, cognitive, and functional abilities while also supporting their emotional well-being. At Apollo Hospitals Navi Mumbai, the programme brings together a collaborative team of pediatricians, physiotherapists, rehabilitation specialists, nurses, and allied healthcare professionals who work closely to develop personalised recovery plans tailored to each child’s needs.   The newly introduced unit combines advanced rehabilitation therapies with a child-friendly clinical environment to address neurological, orthopedic, developmental, and post-surgical rehabilitation requirements. Beyond medical recovery, the focus is on helping children rebuild confidence, independence, and essential life skills that contribute to healthy growth and long-term well-being.  Apollo Hospitals Navi Mumbai, a JCI and NABH-accredited tertiary care centre, is recognised for its multidisciplinary expertise and advanced pediatric services. The expansion of specialised rehabilitation care reflects the hospital’s continued commitment to delivering holistic, patient-centred treatment for children and their families. With this initiative, Apollo Hospitals further reinforces its focus on innovation in pediatric healthcare, ensuring that young patients receive comprehensive support to recover, rebuild strength, and achieve their fullest potential.  

Apollo Sage Hospitals has launched an Advanced Liver Disease & Transplant Clinic in Bhopal, further strengthening its commitment to delivering specialised healthcare in Central India. The new centre builds on the hospital’s advanced liver care services and marks a significant milestone in expanding its capabilities for solid organ transplantation in the region.  The clinic was inaugurated in the presence of Ms. Shivani Agrawal, Managing Director of Sage Group; Dr. Abhishek Yadav, Senior Director and Liver Transplantation Lead, Apollo Hospitals; and Mr. Dhananjay Kumar, CEO of Apollo Sage Hospitals, along with the transplant team and clinical specialists. Liver disease remains a growing global health challenge and is recognised as the 11th leading cause of death worldwide. Conditions such as cirrhosis, hepatitis B and C, metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease, and liver cancer increasingly require advanced medical management and, in some cases, transplantation. For patients with severe liver failure who meet established clinical criteria, liver transplantation may be a life-saving treatment option.  The new clinic brings together an internationally trained multidisciplinary team of hepatologists, gastroenterologists, GI onco-surgeons, transplant surgeons, and intensivists, providing comprehensive care — from early diagnosis and medical management to advanced surgical interventions such as living and deceased donor liver transplantation. Supported with modern infrastructure and advanced diagnostic technologies, the centre aims to deliver end-to-end liver care for patients in Bhopal and neighbouring regions. By enabling access to specialised expertise locally, Apollo Sage Hospitals is helping reduce the need for patients to travel to metropolitan centres for complex liver treatment while strengthening the region’s capacity for advanced clinical care.